Q Where does the name Atairgin come from?
A Atairgin is a word of Celtic origin relating to reprogenesis or reproduction. Although the platform technology has now expanded into many different areas, Atairgins initial research was in cancers of the female reproductive system.
Q - Is Atairgin stock publicly traded?
A Atairgin is a privately held company funded by a series of preferred stock placements.
Q When will the Atairgin blood tests be available?
A luxury hotels in Spa Clinical trials for the ovarian cancer detection test are nearing completion. The company hopes to have the test commercially available by the second half of 2002.
Q How can I be notified when the test is available?
A By entering your name and e-mail address on the bottom left section of the Website frame or by calling us at (800) 833-1193.
Q How can I enter the clinical trials?
A The ovarian cancer diagnostic clinical trial has been conducted at 7 sites across North America and enrollment is complete. The breast cancer diagnostic trial will also have several sites, with each site handling its own enrollment. As the sites are chosen, we will add them to our website.
Q Will participants in the clinical trials be given their test results?
A These are "blinded" trials. The company will not have access to the trial participants or be contacting them for any reason.
| Adjuvant therapy | Treatment that is added to increase the effectiveness of the primary therapy. |
| Angiogenesis | Blood vessel formation. |
| Antibody | A protein in the blood that fights against an invading foreign agent (antigen). |
| Assay | A test for a particular substance. |
| Autologous transplant | A cancer treatment procedure in which either blood stem cells or bone marrow cells are removed from the patient's body and replaced as adjuvant therapy, generally after chemotherapy. back to alpha menu |
| Benign | Cells or tumors that are not cancerous; incapable of invading nearby tissue or spreading to other parts of the body. |
| Biological therapy | Use of substances produced by the body's own cells to treat a disease. Also, (immunotherapy) treatment to stimulate or restore the ability of the immune system to fight infection and disease. |
| Biopsy | The removal of a sample of tissue or cells for microscopic examination to determine if cancer is present. |
| BRCA-1, BRCA-2 | Genes associated with familial risk for breast and ovarian cancer. |
| Breast cancer | Uncontrolled growth of abnormal breast cells. Back to alpha menu |
| CA-125 | A protein found in the blood that may, at elevated levels, indicate the presence of advanced stage ovarian cancer. The blood test is intended to detect residual ovarian cancer in those patients who have received first line therapy. |
| Cancer | A group of many related diseases that involve uncontrolled growth and spread of abnormal cells. |
| Carcinoma | A form of cancer that develops in tissues covering or lining organs of the body. |
| Carcinoma in situ | Early-stage cancer that is confined to one layer of tissue. |
| Chemotherapy | Treatment with drugs to destroy cancer cells. |
| Clinical trial | A systematic investigation of experimental means to detect, diagnose, prevent or treat disease according to a formal study plan. |
| Cyst | An abnormal sac-like formation that contains fluid or semi-solid material; may be benign or malignant. Back to alpha menu |
| Ductal carcinoma in situ (DCIS) | Noninvasive cancer in which the cancer cells are contained in the ducts and do not have the ability to spread. |
| Gene therapy | Treatment that alters genes, the basic units of heredity found in all cells in the body. |
| High risk | A situation whereby the chance of developing cancer is greater than that normally seen in the general population. |
| Hormones | Chemicals produced by glands in the body that control the actions of certain cells or organs. |
| Hormone replacement therapy (HRT) | The use of hormone-containing medications to treat the effects of hormone loss that accompany menopause. |
| Hysterectomy | Surgical removal of the uterus. Back to alpha menu |
| Immune system | The complex group of cells and organs that defends the body against infection and disease. |
| In situ | An early stage of cancer in which a tumor is confined to the immediate area where it began. |
| Lobes | Milk-producing glands in the female breast. |
| Lobular carcinoma in situ (LCIS) | Originates in the milk-producing glands but does not penetrate through the wall of the lobule. While not a true cancer, it is often classified as a noninvasive cancer and is considered a marker for an increased risk of invasive cancer. |
| LPA | Lysophosphatidic acid |
| LPC | Lysophosphatidylcholine |
| Lymphatic system | The tissues and organs that produce, store and transport cells that fight infection and disease. Back to alpha menu |
| Malignant | Cancerous; capable of invading surrounding tissue and spreading to other parts of the body. |
| Mammogram | An x-ray image of the breast used for screening or diagnosis. |
| Mastectomy | Surgical removal of the breast. |
| Metastasis | Process whereby cancer cells can break away from the tumor and enter the bloodstream or the lymphatic system spreading to other organs. |
| Monoclonal antibodies | Antibodies designed to locate and bind to cancer cells in the body; capable of delivering drugs, toxins or radioactive material directly to the cancer cells. Back to alpha menu |
| Ovarian cancer | Cancer which begins in the ovaries when abnormal cell growth occurs. |
| Ovaries | The pair of female reproductive organs that produce eggs and hormones. |
| Radiation therapy | The use of high-energy x-rays to treat cancer. |
| Risk factor | Any factor that increases a person's chance of developing a disease. Back to alpha menu |
| Screening | A test or procedure used to detect cancer or a pre-cancerous condition in an apparently healthy person with no symptoms. |
| Stem cell | The immature cells in blood and bone marrow from which all mature blood cells develop. |
| Tubal ligation | Tying the fallopian tubes to prevent pregnancy. |
| Tumor | An abnormal mass of tissue that results from excessive cell division. |
| Tumor markers | Substances found in abnormal amounts in the blood, in other body fluids or in tumor tissue of patients with certain types of cancer. Back to alpha menu |
